Skip to main content
. 2021 Mar 9;13(5):1178. doi: 10.3390/cancers13051178

Table 3.

Intra and postoperative outcome of procedures in the whole series and stratified according to period of recruitment.

Variables Whole Series Period 1
(2004–2009)
Period 2
(2010–2015)
Period 3
(2015–2020)
a vs. b a vs. c b vs. c a vs. b vs. c
1212 293 353 566
Operating time, median (range) Minutes 240 (150–640) 300 (220–640) 220 (180–510) 250 (150–590) NS NS NS NS
Blood loss, median (range) mL 280 (100–1600) 400 (100–1200) 250 (100–1400) 300 (100–1600) 0.04 NS NS NS
Pringle maneuvre, n (%) 1053 (86.9) 261 (89.1) 309 (87.5) 483 (85.3) NS NS NS NS
Length of Pringle manouevre, median (range) Minutes 40 (15–135) 30 (10–110) 55 (10–120) 45 (10–135) 0.04 0.05 NS 0.05
Intraoperative blood transfusion, n (%) 96 (7.9) 21 (7.2) 34 (9.6) 41 (7.2) NS NS NS NS
Depth of liver margin, median (range) mm 5 (0–11) 9 (0–22) 8 (0–19) 4 (0–11) NS 0.02 0.04 0.03
Time to first flatus, median (range) days 3 (2–6) 3 (2–6) 3 (2–6) 3 (2–6) NS NS NS NS
Return to diet, median (range) days 1 (0–6) 1 (0–5) 1 (0–6) 1 (0–4) NS NS NS NS
Morbidity, n (%) 295 (24.3) 75 (25.6) 90 (25.4) 130 (22.9) NS NS NS NS
Minor Morbidity (Dindo-Clavien I–II) 201 (16.6) 55 (18.7) 56 (15.9) 90 (15.9) NS NS NS NS
Major Morbidity (Dindo-Clavien III–V) 94 (7.8) 20 (6.8) 34 (9.6) 40 (7.1) NS NS NS NS
Mortality, n (%) 19 (1.6) 5 (1.7) 7 (1.9) 7 (1.2) NS NS NS NS
Postoperative transfusions, n (%) 178 (14.7) 51 (17.4) 63 (17.8) 64 (11.3) NS 0.04 0.05 0.05
Total transfusions, n (%) 223 (18.4) 61 (20.8) 72 (20.4) 90 (15.9) NS NS NS NS
Lenght of postoperative stay, median (range) days 5 (1–49) 6 (1–38) 5 (1–49) 5 (1–43) NS NS NS NS